Westmount Partners »

Allogene Therapeutics shares owned by Westmount Partners

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Westmount Partners from 13F filings

Historical chart of Westmount Partners investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Westmount Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Westmount Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $75k 36k 2.08

More positions owned by Westmount Partners

Apple (AAPL)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Amazon (AMZN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Ishares Tr Core S&p500 Etf (IVV)
Caci Intl Cl A (CACI)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Total Stk Mkt (VTI)
Wal-Mart Stores (WMT)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Westmount Partners

Top funds holding Allogene Therapeutics

Pfizer
BlackRock
Tpg Gp A
State Street Corporation
PRIMECAP Management Company
Vanguard Capital Management
Citadel Advisors
T. Rowe Price Associates
Two Sigma Investments
Geode Capital Management
Frazier Life Sciences Management
Woodline Partners
Patient Square Capital
Marshall Wace
Millennium Management

View all funds holding Allogene Therapeutics